DE69634080D1 - Mittel zur verhinderung der truebung der vorderen linsenkapsel - Google Patents

Mittel zur verhinderung der truebung der vorderen linsenkapsel

Info

Publication number
DE69634080D1
DE69634080D1 DE69634080T DE69634080T DE69634080D1 DE 69634080 D1 DE69634080 D1 DE 69634080D1 DE 69634080 T DE69634080 T DE 69634080T DE 69634080 T DE69634080 T DE 69634080T DE 69634080 D1 DE69634080 D1 DE 69634080D1
Authority
DE
Germany
Prior art keywords
preventing
turning
front lens
lens capsule
surgery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634080T
Other languages
English (en)
Other versions
DE69634080T2 (de
Inventor
Katarina Edsman
Carl-Gustaf Goelander
Kerstin Wickstroem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMO Uppsala AB
Original Assignee
Pfizer Health AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health AB filed Critical Pfizer Health AB
Application granted granted Critical
Publication of DE69634080D1 publication Critical patent/DE69634080D1/de
Publication of DE69634080T2 publication Critical patent/DE69634080T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
DE69634080T 1995-05-05 1996-05-03 Mittel zur verhinderung der truebung der vorderen linsenkapsel Expired - Lifetime DE69634080T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9501671 1995-05-05
SE9501671A SE9501671D0 (sv) 1995-05-05 1995-05-05 Method and composition for prevention of posterior capsule opacification
PCT/SE1996/000588 WO1996034629A1 (en) 1995-05-05 1996-05-03 Method and composition for prevention of posterior capsule opacification

Publications (2)

Publication Number Publication Date
DE69634080D1 true DE69634080D1 (de) 2005-01-27
DE69634080T2 DE69634080T2 (de) 2006-03-02

Family

ID=20398207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634080T Expired - Lifetime DE69634080T2 (de) 1995-05-05 1996-05-03 Mittel zur verhinderung der truebung der vorderen linsenkapsel

Country Status (7)

Country Link
EP (1) EP0825877B1 (de)
JP (1) JPH11504342A (de)
AT (1) ATE285252T1 (de)
AU (1) AU5784096A (de)
DE (1) DE69634080T2 (de)
SE (1) SE9501671D0 (de)
WO (1) WO1996034629A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482230B1 (en) 1998-04-15 2002-11-19 Alcon Manufacturing, Ltd. Lens epithelial cell growth assay for intraocular lens materials
CA2317441C (en) 1998-04-15 2007-12-18 Alcon Laboratories, Inc. Intraocular lens coating compositions
US6455318B1 (en) 1998-04-15 2002-09-24 Alcon Manufacturing, Ltd. Collagen IV adhesion assay for intraocular lens materials
CN1188178C (zh) * 1998-04-15 2005-02-09 阿尔康实验室公司 双组分人工晶体及其制造方法
US6491721B2 (en) 1998-04-15 2002-12-10 Alcon Manufacturing, Ltd. Toric intraocular lens material
WO2006034383A1 (en) * 2004-09-21 2006-03-30 Advanced Medical Optics, Inc. Viscoelastic solution or gel formulation, and methods of treating a body site with the same
SE0402272D0 (sv) 2004-09-21 2004-09-21 Amo Groningen Bv Methods of treating a body site with a viscoelastic preparation
JP6346265B2 (ja) * 2013-03-21 2018-06-20 ジェニスフィア・エルエルシー Ｄｎａインターカレーティング剤の細胞送達

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2014244A1 (en) * 1989-04-13 1990-10-13 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines

Also Published As

Publication number Publication date
ATE285252T1 (de) 2005-01-15
DE69634080T2 (de) 2006-03-02
AU5784096A (en) 1996-11-21
JPH11504342A (ja) 1999-04-20
EP0825877B1 (de) 2004-12-22
EP0825877A1 (de) 1998-03-04
WO1996034629A1 (en) 1996-11-07
SE9501671D0 (sv) 1995-05-05

Similar Documents

Publication Publication Date Title
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
ES2180683T3 (es) Preparacion de nifedipina de liberacion con duracion prolongada.
DK0939626T3 (da) Galenisk form til forlænget frigivelse af milnacipran
HUP9802665A3 (en) Composition for controlled release of miotic and mydriatic drugs in the anterior chamber
GR3035415T3 (en) Oral pharmaceutical compositions for specific colon delivery.
GEP20012375B (en) Isothiazolones, Pharmaceutical Composition on Their Basis and Method for Obtaining the Same
DE69804918T2 (de) Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
AU7239996A (en) Inhibition of tumor necrosis factor alpha
MY130098A (en) Local drug delivery film for periodontal treatment
DE69634080D1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
IL124858A0 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
GEP20043377B (en) Pharmaceutical Complex
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
HRP20000704B1 (en) Controlled release peroral compositions of levosimendan
MY114610A (en) Controlled drug delivery system for diltiazem.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ADVANCED MEDICAL OPTICS UPPSALA AB, UPPSALA, SE

8327 Change in the person/name/address of the patent owner

Owner name: AMO UPPSALA AB, UPPSALA, SE